ExodusPoint Capital Management’s Olema Oncology OLMA Stock Holding History
Bought
Maintained
Sold
Other funds holding OLMA
SL
ExodusPoint Capital Management's OLMA Position: Q3 2026 in Review
ExodusPoint Capital Management sold out of Olema Oncology (OLMA) in Q3 2026, closing a stake of 70,142 shares — an estimated $877K sold.
ExodusPoint Capital Management first reported a position in OLMA in Q4 2020 and held it in 7 quarters. The position peaked at $3.77M in Q4 2025. 179 funds tracked by Wall St. Rank hold OLMA as of Q3 2026.
- ExodusPoint Capital Management reported no remaining Olema Oncology position as of Q3 2026 after selling out during the quarter.
- ExodusPoint Capital Management sold 70,142 Olema Oncology shares in Q3 2026, an estimated $877K.
- ExodusPoint Capital Management first reported a position in Olema Oncology in Q4 2020 and held it in 7 quarters.
- ExodusPoint Capital Management's Olema Oncology position peaked at $3.77M in Q4 2025.
- 179 funds tracked by Wall St. Rank held Olema Oncology as of Q3 2026.
Based on ExodusPoint Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.